EJ, K., EJ, K., HJ, C., J, O., HS, P., CS, R., . . . NK, K. (2022). Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer. Genes & genomics, 44(6), 659. https://doi.org/10.1007/s13258-022-01246-9
Chicago Style (17th ed.) CitationEJ, Ko, et al. "Prognostic Significance of Three Endothelial Nitric Oxide Synthase (eNOS) Polymorphisms and Metabolic Syndrome (MetS) in Patients with Colorectal Cancer." Genes & Genomics 44, no. 6 (2022): 659. https://doi.org/10.1007/s13258-022-01246-9.
MLA (9th ed.) CitationEJ, Ko, et al. "Prognostic Significance of Three Endothelial Nitric Oxide Synthase (eNOS) Polymorphisms and Metabolic Syndrome (MetS) in Patients with Colorectal Cancer." Genes & Genomics, vol. 44, no. 6, 2022, p. 659, https://doi.org/10.1007/s13258-022-01246-9.